BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24876671)

  • 1. Chrysophanol inhibits NALP3 inflammasome activation and ameliorates cerebral ischemia/reperfusion in mice.
    Zhang N; Zhang X; Liu X; Wang H; Xue J; Yu J; Kang N; Wang X
    Mediators Inflamm; 2014; 2014():370530. PubMed ID: 24876671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in mice.
    Franke M; Bieber M; Kraft P; Weber ANR; Stoll G; Schuhmann MK
    Brain Behav Immun; 2021 Feb; 92():223-233. PubMed ID: 33307174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion.
    Wang H; Chen H; Jin J; Liu Q; Zhong D; Li G
    Life Sci; 2020 Jun; 251():117638. PubMed ID: 32251636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway.
    Ma C; Wang X; Xu T; Yu X; Zhang S; Liu S; Gao Y; Fan S; Li C; Zhai C; Cheng F; Wang Q
    BMC Complement Altern Med; 2019 Nov; 19(1):320. PubMed ID: 31747940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bakuchiol ameliorates cerebral ischemia-reperfusion injury by modulating NLRP3 inflammasome and Nrf2 signaling.
    Xu Y; Gao X; Wang L; Yang M; Xie R
    Respir Physiol Neurobiol; 2021 Oct; 292():103707. PubMed ID: 34087492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway.
    Dong W; Yang R; Yang J; Yang J; Ding J; Wu H; Zhang J
    Int J Clin Exp Pathol; 2015; 8(8):8731-41. PubMed ID: 26464617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury.
    Hou Y; Wang Y; He Q; Li L; Xie H; Zhao Y; Zhao J
    Behav Brain Res; 2018 Jan; 336():32-39. PubMed ID: 28851669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective Effects of Vinpocetine Against Ischemia-Reperfusion Injury Via Inhibiting NLRP3 Inflammasome Signaling Pathway.
    Hou B; Li D; Wang D; Jiang C; Wang G; Wang D; Yan G; Guo X; Zhao L; Wan Z; Fan C; Cao W; Ren H
    Neuroscience; 2023 Aug; 526():74-84. PubMed ID: 37290685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal administration of β-1, 3-galactosyltransferase 2 confers neuroprotection against ischemic stroke by likely inhibiting oxidative stress and NLRP3 inflammasome activation.
    Guo X; Zhang Y; Liu C; Ren L; Gao S; Bi J; Liang J; Wang P
    FASEB J; 2022 Oct; 36(10):e22542. PubMed ID: 36094000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia.
    Zhang C; Boini KM; Xia M; Abais JM; Li X; Liu Q; Li PL
    Hypertension; 2012 Jul; 60(1):154-62. PubMed ID: 22647887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbelliferone ameliorates cerebral ischemia-reperfusion injury via upregulating the PPAR gamma expression and suppressing TXNIP/NLRP3 inflammasome.
    Wang X; Li R; Wang X; Fu Q; Ma S
    Neurosci Lett; 2015 Jul; 600():182-7. PubMed ID: 26071904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed NLRP3 inflammasome inhibition ameliorates subacute stroke progression in mice.
    Bellut M; Bieber M; Kraft P; Weber ANR; Stoll G; Schuhmann MK
    J Neuroinflammation; 2023 Jan; 20(1):4. PubMed ID: 36600259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XingNaoJing injections protect against cerebral ischemia/reperfusion injury and alleviate blood-brain barrier disruption in rats, through an underlying mechanism of NLRP3 inflammasomes suppression.
    Qu XY; Zhang YM; Tao LN; Gao H; Zhai JH; Sun JM; Song YQ; Zhang SX
    Chin J Nat Med; 2019 Jul; 17(7):498-505. PubMed ID: 31514981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IMM-H004 therapy for permanent focal ischemic cerebral injury via CKLF1/CCR4-mediated NLRP3 inflammasome activation.
    Ai QD; Chen C; Chu S; Zhang Z; Luo Y; Guan F; Lin M; Liu D; Wang S; Chen N
    Transl Res; 2019 Oct; 212():36-53. PubMed ID: 31176667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective role of Tongxinluo on blood-brain barrier after ischemia-reperfusion brain injury.
    Liu Y; Tang GH; Sun YH; Lin XJ; Wei C; Yang GY; Liu JR
    J Ethnopharmacol; 2013 Jul; 148(2):632-9. PubMed ID: 23707212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroacupuncture attenuated cerebral ischemic injury and neuroinflammation through α7nAChR-mediated inhibition of NLRP3 inflammasome in stroke rats.
    Jiang T; Wu M; Zhang Z; Yan C; Ma Z; He S; Yuan W; Pu K; Wang Q
    Mol Med; 2019 May; 25(1):22. PubMed ID: 31117961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1-dependent autophagy induction.
    He Q; Li Z; Wang Y; Hou Y; Li L; Zhao J
    Int Immunopharmacol; 2017 Sep; 50():208-215. PubMed ID: 28683365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phthalide derivative CD21 ameliorates ischemic brain injury in a mouse model of global cerebral ischemia: involvement of inhibition of NLRP3.
    Li X; Shi MQ; Chen C; Du JR
    Int Immunopharmacol; 2020 Sep; 86():106714. PubMed ID: 32593156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signaling.
    Zhao J; Piao X; Wu Y; Liang S; Han F; Liang Q; Shao S; Zhao D
    Biomed Pharmacother; 2020 Jul; 127():110151. PubMed ID: 32559840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idebenone attenuates cerebral inflammatory injury in ischemia and reperfusion via dampening NLRP3 inflammasome activity.
    Peng J; Wang H; Gong Z; Li X; He L; Shen Q; Pan J; Peng Y
    Mol Immunol; 2020 Jul; 123():74-87. PubMed ID: 32438202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.